Clin2
NCT07595263Possibly a fitRecruiting

Ulonivirine and Methadone Interaction Study in Healthy Adults

Healthy

Treatments studied

This research study tests how a new drug called ulonivirine works with methadone in people who are stable on methadone treatment. The goal is to understand if these two medications can be safely used together without problems.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
14 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are in overall good health with no serious medical conditions
  • Your body mass index (BMI, a measure of weight relative to height) is between 18 and 40
  • You have been on a stable, unchanged dose of methadone for at least 2 weeks before starting the study
  • You have been reliably attending your methadone maintenance program for at least 2 months
  • You have not had cancer in the past
  • You do not have a history of severe allergies or bad reactions to medications

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05093972Not yet recruiting· Phase 1
Testing a new drug in people with mild or moderate liver problems

This study tests an experimental drug called ulonivirine to see how the body processes it in people with mild or moderate liver problems compared to healthy volunteers. It helps doctors understand if the drug is safe and how it should be dosed for people with liver disease.

NCT07314346Recruiting· Phase 1
Study of a new hepatitis C drug with addiction medications

This study checks how a new hepatitis C medicine (bemnifosbuvir/ruzasvir) interacts with medications used for opioid addiction, such as buprenorphine/naloxone or methadone. It helps doctors understand if the new medicine is safe and effective for people taking these addiction treatments.

Hollywood, Florida
NCT05789173Recruiting· Early Phase 1
Testing how genetics affect drug levels with methadone

This early study tests how a person’s genetic makeup may change how fast certain medicines move through the body. It compares drug levels when combined with methadone and tizanidine, aiming to understand safer dosing and effects.

Indianapolis, Indiana
NCT07525544Recruiting· Phase 1
Safety Study of VH4770359 in Healthy Adults

This is an early-stage safety study testing a new investigational drug (VH4770359) in healthy volunteers. Researchers want to understand how the body processes the drug and ensure it is safe and well-tolerated.

Baltimore, Maryland
NCT05490732Recruiting
Methadone dose blood-level study and monitoring

This study measures how methadone moves through your body by using planned blood samples and computer modeling. It may help doctors better predict methadone levels to support safer dosing for people already taking methadone.

Montpellier
NCT05620940Recruiting· Phase 1
IV drug safety and absorption study in healthy men

This Phase 1 study tests two experimental medicines given by IV to healthy men. It checks safety and how the body absorbs and processes the drugs (their “pharmacokinetic” profile).

Herston, Queensland

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.